Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New mammal species enters human gene mutation equation in Germany:

This article was originally published in Clinica

Executive Summary

A lull in avian flu developments in Europe - since a spate of outbreaks in France recently put the EU on alert - has been broken by the discovery of the H5N1 virus in a new mammalian species in Germany. Although the infection of a stone marten has been attributed to contact with infected wild birds, the World Health Organization says it could indicate changes in the virus, which might facilitate human infection. "Further investigation is needed to determine whether evidence of H5N1 infection in new mammalian species has any significance for the risk of human infection or the potential of this virus to adapt to mammals, including humans," said the WHO.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051113

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel